[Clinical aspects of pelvic histangiopathies. New therapeutic possibilities with danazol].

Abstract

Menometrorrhagia and hypermenorrhoea are often present in patients who also suffer from a state of insufficiency of the utero-adnexal venous system interpretable as a clinical entity of system pathology and accompanied by pictures of acquired venous ectasis. The lack of any easy clinical characteristic objectivisation often prevents easy recognition and complex diagnostic investigation is therefore indispensable. Treatment is often destructive surgery following the failure of the various medical or conservative surgical therapies that are tried. Personal experience in cases in which the clinical picture (big uterus, menometrorrhagia, pelvic pain) presents a pathology of the venous vascular system, can report considerable benefit first and disappearance later of the symptomatology, with treatment using danazol at a dose of 200-300-400 mg/die. This makes demolition surgery, which is not often well accepted by the patient, inopportune.

• Authors: C Durando, A Durando, G Maina, A Vercelli
• Journal: Minerva ginecologica (Minerva Ginecol) Vol. 43 Issue 9 Pg. 397-403 (Sep 1991) ISSN: 0026-4784 [Print] Italy
• Vernacular Title: Alcuni aspetti clinici delle istangiopatie pelviche. Nuove possibilità di terapia con danazolo.
• PMID: 1945028 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Danazol

Topics

• Adnexa Uteri (blood supply)
• Adult
• Danazol (therapeutic use)
• Female
• Humans
• Menorrhagia (drug therapy, etiology)
• Metrorrhagia (drug therapy, etiology)
• Pelvis (blood supply)
• Uterine Diseases (drug therapy)
• Uterus (blood supply, pathology)
• Varicose Veins (complications, drug therapy)